Kaneko, Tomohiro
Miyazaki, Sakiko
Kurita, Azusa
Morimoto, Ryoko
Tsuchiya, Shun
Watanabe, Naoki
Takaku, Tomoiku
Komatsu, Norio
Minamino, Tohru
Article History
Received: 10 February 2022
Accepted: 15 February 2023
First Online: 22 February 2023
Declarations
:
: Approval was obtained from the ethics committee of Juntendo University (Approval number: H19-0191). The procedures used in this study adhered to the tenets of the Declaration of Helsinki.
: Not applicable.
: Tomoiku Takaku has received honoraria for lectures from Novartis, Pfizer, and Otsuka Pharmaceutical and research funding from Bristol Myers Squibb and Otsuka Pharmaceutical. Norio Komatsu was a board member of PharmaEssentia Japan, and received honoraria from Abbvie, Celgene, Otsuka Pharmaceutical Co., Ltd, Japan Tobacco Inc., Shire, Japan, Novartis, and Takeda Pharmaceutical Company Limited. None of the other authors have competing interests to declare.